Severe Asthma, MepolizumaB and Affect: SAMBA Study
| 対象疾患 | Severe Eosinophilic Asthma, Psychological Distress, Anxiety, Depression |
|---|---|
| 相 | 該当なし |
| スポンサー | University Hospital Southampton NHS Foundation Trust |
| ステータス | 完了 |
| 参加者数 | 120 名 |
| 介入（薬剤） | no study intervention. Patients receive standard clinical care |
| 開始日 | 2021年9月9日 |
| 完了日 | 2025年3月26日 |
| 結果公開日 | 2026年7月13日 |
概要
This is a real-life pragmatic non-randomised study to explore the impact of mepolizumab on the emotional and affective outcomes of patients with severe eosinophilic asthma and their partners. It will be conducted in two quantitative stages (Phases 1 and 2) with an additional third qualitative component (Phase 3).
Change in Emotional Composition (Using the Geneva Emotions Wheel)
| Patients With Severe Eosinophilic Asthma Phase 2 | 0.9 score |
|---|---|
| Partners of Patients With Severe Eosinophilic Asthma Phase 2 | 0.1 score |
| Patients With Severe Eosinophilic Asthma Phase 2 | 0.7 score |
| Partners of Patients With Severe Eosinophilic Asthma Phase 2 | 0.0 score |
| Patients With Severe Eosinophilic Asthma Phase 2 | 0.0 score |
| Partners of Patients With Severe Eosinophilic Asthma Phase 2 | 0.2 score |
BENITIONS で見る ClinicalTrials.gov の原文を見る
同じ疾患の他の治験
- CBT+ for Depression — University of Wisconsin, Madison
- Probing the Dorsolateral Prefrontal Cortex and Central Executive Network for Improving Neu — Stanford University
- Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for — Levomecor Inc.
- A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major De — Levomecor Inc.
- Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders — Massachusetts General Hospital
- Individualized Functional Connectivity Targeting in aiTBS for Depression — Brigham and Women's Hospital